Ads
related to: belimumab b cell activity- Dosing And Administration
View Information On The Dosing &
Administration Of BENLYSTA.
- How Does BENLYSTA Work?
Discover Facts Related To The MOA
Of BENLYSTA To Learn How It Works.
- Financial Assistance
Out-of-Pocket Costs Keep Climbing.
See How We May Be Able To Help.
- Clinical Information
View The Clinical Information And
Data For BENLYSTA To Learn More.
- Vial Calculator Tool
Utilize The Vial Calculator Tool On
The Official BENLYSTA HCP Website.
- Infusion Scheduler Info
Access The Infusion Scheduler For
BENLYSTA To Help Start Patients.
- Dosing And Administration
Search results
Results From The WOW.Com Content Network
Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), [6] also known as B-lymphocyte stimulator (BLyS). [7] It is approved in the United States [ 8 ] and Canada, [ 9 ] and the European Union [ 5 ] to treat systemic lupus erythematosus and lupus nephritis.
Belimumab (Benlysta) is a monoclonal antibody developed by Human Genome Sciences and GlaxoSmithKline, with significant discovery input by Cambridge Antibody Technology, which specifically recognizes and inhibits the biological activity of B-Lymphocyte stimulator (BLyS) and is in clinical trials for treatment of Systemic lupus erythematosus and ...
B cells have a variety of functions including being an efficient APC, contribute to T cell activation, produce cytokines that promote the permeation of leukocytes into the joints and more. [21] The therapeutic effect of B cells inhibitor is dependent on the disruption of these diverse functions. Examples: [16] Belimumab; Rituximab
B cells, unlike the other two classes of lymphocytes, T cells and natural killer cells, express B cell receptors (BCRs) on their cell membrane. [1] BCRs allow the B cell to bind to a foreign antigen, against which it will initiate an antibody response. [1] B cell receptors are extremely specific, with all BCRs on a B cell recognizing the same ...
Atacicept is a recombinant fusion protein designed to inhibit B cells, thereby suppressing autoimmune disease.The designer protein combines the binding site for two cytokines that regulate maturation, function, and survival of B cells – B-lymphocyte stimulator (BLyS) and A proliferation-inducing ligand (APRIL), with the constant region of immunoglobin. [1]
From ancient history to the modern day, the clitoris has been discredited, dismissed and deleted -- and women's pleasure has often been left out of the conversation entirely. Now, an underground art movement led by artist Sophia Wallace is emerging across the globe to challenge the lies, question the myths and rewrite the rules around sex and the female body.
Ads
related to: belimumab b cell activity